264 related articles for article (PubMed ID: 30460757)
1. CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells.
Uscanga-Palomeque AC; Calvillo-Rodríguez KM; Gómez-Morales L; Lardé E; Denèfle T; Caballero-Hernández D; Merle-Béral H; Susin SA; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
Cancer Sci; 2019 Jan; 110(1):256-268. PubMed ID: 30460757
[TBL] [Abstract][Full Text] [Related]
2. PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice with Tumoral T Lymphoblasts.
Martínez-Torres AC; Calvillo-Rodríguez KM; Uscanga-Palomeque AC; Gómez-Morales L; Mendoza-Reveles R; Caballero-Hernández D; Karoyan P; Rodríguez-Padilla C
J Oncol; 2019; 2019():9852361. PubMed ID: 31275386
[TBL] [Abstract][Full Text] [Related]
3. PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells.
Calvillo-Rodríguez KM; Mendoza-Reveles R; Gómez-Morales L; Uscanga-Palomeque AC; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
Oncoimmunology; 2022; 11(1):2054305. PubMed ID: 35402082
[TBL] [Abstract][Full Text] [Related]
4. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.
Martinez-Torres AC; Quiney C; Attout T; Boullet H; Herbi L; Vela L; Barbier S; Chateau D; Chapiro E; Nguyen-Khac F; Davi F; Le Garff-Tavernier M; Moumné R; Sarfati M; Karoyan P; Merle-Béral H; Launay P; Susin SA
PLoS Med; 2015 Mar; 12(3):e1001796. PubMed ID: 25734483
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 mimic peptide PKHB1 induced endoplasmic reticulum stress-mediated but CD47-independent apoptosis in non-small cell lung cancer.
Ye J; Yao Y; Zhao J; Cui L; Lu G; Wang Q; Zhang P; Zhou J
Drug Dev Res; 2023 Apr; 84(2):238-252. PubMed ID: 36598070
[TBL] [Abstract][Full Text] [Related]
6. Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
Pramil E; Herbi Bastian L; Denèfle T; Nemati F; Xiao M; Lardé E; Maloum K; Roos-Weil D; Chapiro E; Le Garff-Tavernier M; Davi F; Decaudin D; Sarfati M; Nguyen-Khac F; Merle-Béral H; Karoyan P; Susin SA
Blood Adv; 2019 Oct; 3(20):2920-2933. PubMed ID: 31648314
[TBL] [Abstract][Full Text] [Related]
7. CD47-ligation induced cell death in T-acute lymphoblastic leukemia.
Leclair P; Liu CC; Monajemi M; Reid GS; Sly LM; Lim CJ
Cell Death Dis; 2018 May; 9(5):544. PubMed ID: 29748606
[TBL] [Abstract][Full Text] [Related]
8. Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells.
Saumet A; Slimane MB; Lanotte M; Lawler J; Dubernard V
Blood; 2005 Jul; 106(2):658-67. PubMed ID: 15784731
[TBL] [Abstract][Full Text] [Related]
9. Peptide analogues PKHB1 and 4N1K induce cell death through CD47-independent mechanisms.
Leclair P; Kim MJ; Lim CJ
Cancer Sci; 2020 Mar; 111(3):1028-1030. PubMed ID: 32043743
[No Abstract] [Full Text] [Related]
10. Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells.
Denèfle T; Pramil E; Gómez-Morales L; Levasseur MD; Lardé E; Newton C; Herry K; Herbi L; Lamotte Y; Odile E; Ancellin N; Grondin P; Martinez-Torres AC; Viviani F; Merle-Beral H; Lequin O; Susin SA; Karoyan P
J Med Chem; 2019 Sep; 62(17):7656-7668. PubMed ID: 31403795
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia.
Yang K; Xu J; Liu Q; Li J; Xi Y
Pathol Res Pract; 2019 Feb; 215(2):265-271. PubMed ID: 30466764
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.
Mateo V; Brown EJ; Biron G; Rubio M; Fischer A; Deist FL; Sarfati M
Blood; 2002 Oct; 100(8):2882-90. PubMed ID: 12351399
[TBL] [Abstract][Full Text] [Related]
14. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
Zhang X; Huang H; Xu Z; Zhan R
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
[TBL] [Abstract][Full Text] [Related]
15. The anticancer peptide RT53 induces immunogenic cell death.
Pasquereau-Kotula E; Habault J; Kroemer G; Poyet JL
PLoS One; 2018; 13(8):e0201220. PubMed ID: 30080874
[TBL] [Abstract][Full Text] [Related]
16. MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47.
Huang W; Wang WT; Fang K; Chen ZH; Sun YM; Han C; Sun LY; Luo XQ; Chen YQ
Mol Cancer; 2018 Jan; 17(1):12. PubMed ID: 29368647
[TBL] [Abstract][Full Text] [Related]
17. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity.
Sethuraman SN; Singh MP; Patil G; Li S; Fiering S; Hoopes PJ; Guha C; Malayer J; Ranjan A
Theranostics; 2020; 10(8):3397-3412. PubMed ID: 32206098
[No Abstract] [Full Text] [Related]
18. Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL.
Müller K; Vogiatzi F; Winterberg D; Rösner T; Lenk L; Bastian L; Gehlert CL; Autenrieb MP; Brüggemann M; Cario G; Schrappe M; Kulozik AE; Eckert C; Bergmann AK; Bornhauser B; Bourquin JP; Valerius T; Peipp M; Kellner C; Schewe DM
Blood; 2022 Jul; 140(1):45-57. PubMed ID: 35452517
[TBL] [Abstract][Full Text] [Related]
19. PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis.
He Y; Wang C; Liang Q; Guo R; Jiang J; Shen W; Hu K
Front Pharmacol; 2022; 13():1048978. PubMed ID: 36532743
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure-Activity Relationship Studies.
Denèfle T; Boullet H; Herbi L; Newton C; Martinez-Torres AC; Guez A; Pramil E; Quiney C; Pourcelot M; Levasseur MD; Lardé E; Moumné R; Ogi FX; Grondin P; Merle-Beral H; Lequin O; Susin SA; Karoyan P
J Med Chem; 2016 Sep; 59(18):8412-21. PubMed ID: 27526615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
